Industry

DUBLIN–(BUSINESS WIRE)–The “Global Over-The-Counter (OTC) Veterinary Drugs Market Outlook to 2032” report has been added to ResearchAndMarkets.com’s offering. This report on the Over-The-Counter (OTC) veterinary drugs market offers a global industry analysis for 2017-2021 and an opportunity assessment for 2022-2032. The report consists of a comprehensive assessment of the most important market dynamics. On conducting … [Read more…]

PORTSMOUTH, N.H.–(BUSINESS WIRE)–Epredia, a global leader in precision cancer diagnostics, today announced that its parent company PHC Holdings Corporation [TSE 6523] has acquired anatomical pathology suppliers Microm Microtech France (MMFrance) and Laurypath in a strategic expansion of Epredia’s presence in Europe. MMFrance and Laurypath, both founded in 1987 in Lyon, France, manufacture and supply anatomical … [Read more…]

BOSTON–(BUSINESS WIRE)–Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a poster presentation titled: High Activity of Poziotinib in G778_P780dup HER2 Exon 20 Insertion Mutations in Non-Small Lung Cancer (NSCLC). The poster will be presented at the upcoming European Society for Medical Oncology Congress (ESMO) 2022 that will … [Read more…]

Approval based on TOPAZ-1 Phase III trial results, which showed IMFINZI combination reduced risk of death by 20% vs. chemotherapy alone WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca’s IMFINZI® (durvalumab) has been approved in the US for the treatment of adult patients with locally advanced or metastatic biliary tract cancer (BTC) in combination with chemotherapy (gemcitabine plus cisplatin). The … [Read more…]

Long-term data continue to reinforce benefits of Opdivo (nivolumab)-based combinations Response outcomes data continue to build upon the clinical evidence of Opdualag (nivolumab and relatlimab-rmbw) in advanced melanoma Exploratory analyses in non-small cell lung cancer and urothelial carcinoma support the potential benefit of immunotherapy in earlier stages of cancer PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #ESMO—Bristol Myers Squibb … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Biosimilars Global Market Opportunities And Strategies To 2031” report has been added to ResearchAndMarkets.com’s offering. The global biosimilars market reached a value of nearly $11,418.9 million in 2021, having grown at a compound annual growth rate (CAGR) of 34.8% since 2016. The market is expected to grow from $11,418.9 million in 2021 to … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Recombinant Cell Culture Supplements Market: Focus on Pricing Analysis, Product, Application, Expression System, and Region – Analysis and Forecast, 2022-2032” report has been added to ResearchAndMarkets.com’s offering. The global recombinant cell culture supplements market was estimated at $308.6 million in 2021 and is expected to reach $1,188.6 million by 2032, growing at … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Single-use Bioprocessing Market By Product, By Application, By Method, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030” report has been added to ResearchAndMarkets.com’s offering. ‘Single-use Bioprocessing Market,’ was valued at $7.0 billion in 2020, and is estimated to reach $38.8 billion by 2030, growing at a CAGR of 18.4% from 2021 … [Read more…]

LONDON & WETHERBY, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, announces that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to the company’s lead pre|CISION drug candidate, AVA6000, for treatment of soft … [Read more…]

Onera Health announces the launch of Onera Polysomnography-as-a-Service in selected European markets at the International Congress 2022 of the European Respiratory Society (ERS). EINDHOVEN, The Netherlands–(BUSINESS WIRE)–Onera Health, a leader in transforming sleep medicine and remote monitoring, announced today the official launch of its ground-breaking solution to diagnose sleep disorders in Europe. The service is … [Read more…]